申请人:——
公开号:US20030027836A1
公开(公告)日:2003-02-06
A heterocyclic compound of the formula [I]
1
wherein R
1
is hydrogen atom or lower alkyl, R
2
is hydrogen atom, alkyl optionally having a substituent and the like, R
3
is hydrogen atom, lower alkyl and the like, A is a single bond or >N—R
5
wherein R
5
is hydrogen atom or lower alkyl, B is lower alkylene, and Y is aryl optionally having a substituent and the like, and a pharmaceutically acceptable salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin resistance improver, a therapeutic agent of diabetes, a therapeutic agent of diabetic complication, a glucose tolerance improver, an anti-atherosclerosis agent, an anti-obesity agent, an antiinflammatory agent, an agent for the prophylaxis or treatment of PPAR-mediated disease and an agent for the prophylaxis or treatment of syndrome X.
一种具有下列化学式[I]的杂环化合物,其中R1是氢原子或较低的烷基,R2是氢原子,烷基或可选地具有取代基等,R3是氢原子,较低的烷基等,A是单键或>N—R5,其中R5是氢原子或较低的烷基,B是较低的亚烷基,Y是芳基或可选地具有取代基等,以及其药学上可接受的盐具有降血糖作用、降血脂作用、改善胰岛素抵抗作用和PPAR激活作用,并且可用作降血糖剂、降血脂剂、改善胰岛素抵抗剂、糖尿病治疗剂、糖尿病并发症治疗剂、葡萄糖耐量改善剂、抗动脉粥样硬化剂、抗肥胖剂、抗炎剂、预防或治疗PPAR介导疾病的药剂和预防或治疗X综合征的药剂。